You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 16, April 28, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (94)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Diagnosis
 •Diabetes Mellitus
 •Alert me on articles by topic

Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus

James B. Meigs, MD, MPH; Frank B. Hu, MD, PhD; Nader Rifai, PhD; JoAnn E. Manson, MD, DrPH

JAMA. 2004;291:1978-1986.

Context  Endothelial dysfunction occurs in diagnosed type 2 diabetes mellitus but may also precede development of diabetes.

Objective  To determine whether elevated plasma levels of biomarkers reflecting endothelial dysfunction (E-selectin; intercellular adhesion molecule 1 [ICAM-1]; and vascular cell adhesion molecule 1 [VCAM-1]) predict development of type 2 diabetes in initially nondiabetic women.

Design and Setting  Prospective, nested case-control study within the Nurses' Health Study, an ongoing US study initiated in 1976.

Participants  Of 121 700 women initially enrolled, 32 826 provided blood samples in 1989-1990; of those free of diabetes, cardiovascular disease, or cancer at baseline, 737 developed incident diabetes by 2000. Controls (n = 785) were selected according to matched age, fasting status, and race.

Main Outcome Measure  Risk of confirmed clinically diagnosed type 2 diabetes by baseline levels of E-selectin, ICAM-1, and VCAM-1.

Results  Baseline median levels of the biomarkers were significantly higher among cases than among controls (E-selectin, 61.2 vs 45.4 ng/mL; ICAM-1, 264.9 vs 247.0 ng/mL; VCAM-1, 545.4 vs 526.0 ng/mL [all P values <=.004]). Elevated E-selectin and ICAM-1 levels predicted incident diabetes in logistic regression models conditioned on matching criteria and adjusted for body mass index (BMI), family history of diabetes, smoking, diet score, alcohol intake, activity index, and postmenopausal hormone use. The adjusted relative risks for incident diabetes in the top quintile vs the bottom quintiles were 5.43 for E-selectin (95% confidence interval [CI], 3.47-8.50), 3.56 for ICAM-1 (95% CI, 2.28-5.58), and 1.12 for VCAM-1 (95% CI, 0.76-1.66). Adjustment for waist circumference instead of BMI or further adjustment for baseline levels of C-reactive protein, fasting insulin, and hemoglobin A1c or exclusion of cases diagnosed during the first 4 years of follow-up did not alter these associations.

Conclusion  Endothelial dysfunction predicts type 2 diabetes in women independent of other known risk factors, including obesity and subclinical inflammation.


Author Affiliations: General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School (Dr Meigs); Department of Nutrition, Harvard School of Public Health (Dr Hu); Department of Pathology, Children's Hospital Medical Center and Harvard Medical School (Dr Rifai); Division of Preventive Medicine and the Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, and the Department of Epidemiology, Harvard School of Public Health (Drs Hu and Manson), Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alcohol Consumption, Mediating Biomarkers, and Risk of Type 2 Diabetes Among Middle-Aged Women
Beulens et al.
Diabetes Care 2008;31:2050-2055.
ABSTRACT | FULL TEXT  

Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study
Martinez-Gonzalez et al.
BMJ 2008;336:1348-1351.
ABSTRACT | FULL TEXT  

Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men
Wannamethee et al.
Diabetes Care 2008;31:995-1000.
ABSTRACT | FULL TEXT  

Overweight Latino Children and Adolescents Have Marked Endothelial Dysfunction and Subclinical Vascular Inflammation in Association With Excess Body Fat and Insulin Resistance
Caballero et al.
Diabetes Care 2008;31:576-582.
ABSTRACT | FULL TEXT  

Retinal Arteriolar Narrowing Predicts Incidence of Diabetes: The Australian Diabetes, Obesity and Lifestyle (AusDiab) Study
Nguyen et al.
Diabetes 2008;57:536-539.
ABSTRACT | FULL TEXT  

Cardiovascular Complications in Diabetes: Targets and interventions
Stirban and Tschoepe
Diabetes Care 2008;31:S215-S221.
ABSTRACT | FULL TEXT  

Endothelial Dysfunction and C-Reactive Protein Are Risk Factors for Diabetes in Essential Hypertension
Perticone et al.
Diabetes 2008;57:167-171.
ABSTRACT | FULL TEXT  

Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
Conen et al.
Eur Heart J 2007;28:2937-2943.
ABSTRACT | FULL TEXT  

Inflammation and Endothelial Activation Is Evident at Birth in Offspring of Mothers With Type 1 Diabetes
Nelson et al.
Diabetes 2007;56:2697-2704.
ABSTRACT | FULL TEXT  

Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study
Ingelsson et al.
Circulation 2007;116:984-992.
ABSTRACT | FULL TEXT  

Microvascular Dysfunction in Obesity: A Potential Mechanism in the Pathogenesis of Obesity-Associated Insulin Resistance and Hypertension
Jonk et al.
Physiology 2007;22:252-260.
ABSTRACT | FULL TEXT  

Insulin Resistance: Link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth
Lee et al.
Diabetes Care 2007;30:2091-2097.
ABSTRACT | FULL TEXT  

Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women
Song et al.
Diabetes 2007;56:1898-1904.
ABSTRACT | FULL TEXT  

Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility
O'Neill et al.
Occup. Environ. Med. 2007;64:373-379.
ABSTRACT | FULL TEXT  

Associations Between Lifestyle and Depressed Mood: Longitudinal Results From the Maastricht Aging Study
van Gool et al.
Am. J. Public Health 2007;97:887-894.
ABSTRACT | FULL TEXT  

Relationship between Vascular Reactivity and Lipids in Mexican-Americans with Type 2 Diabetes Treated with Pioglitazone
Wajcberg et al.
J. Clin. Endocrinol. Metab. 2007;92:1256-1262.
ABSTRACT | FULL TEXT  

Interleukin-6 Impairs the Insulin Signaling Pathway, Promoting Production of Nitric Oxide in Human Umbilical Vein Endothelial Cells
Andreozzi et al.
Mol. Cell. Biol. 2007;27:2372-2383.
ABSTRACT | FULL TEXT  

Sex Differences in Endothelial Function Markers Before Conversion to Pre-Diabetes: Does the Clock Start Ticking Earlier Among Women?: The Western New York Study
Donahue et al.
Diabetes Care 2007;30:354-359.
ABSTRACT | FULL TEXT  

Does Hypoadiponectinemia Explain the Increased Risk of Diabetes and Cardiovascular Disease in South Asians?
Retnakaran et al.
Diabetes Care 2006;29:1950-1954.
FULL TEXT  

Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs et al.
J. Clin. Endocrinol. Metab. 2006;91:2906-2912.
ABSTRACT | FULL TEXT  

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study.
Herder et al.
Diabetes 2006;55:2340-2346.
ABSTRACT | FULL TEXT  

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Diamanti-Kandarakis et al.
Hum Reprod 2006;21:1426-1431.
ABSTRACT | FULL TEXT  

Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes: The Framingham Offspring Study
Meigs et al.
Diabetes 2006;55:530-537.
ABSTRACT | FULL TEXT  

Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population
Thorand et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:398-405.
ABSTRACT | FULL TEXT  

Nut and Seed Consumption and Inflammatory Markers in the Multi-Ethnic Study of Atherosclerosis
Jiang et al.
Am J Epidemiol 2006;163:222-231.
ABSTRACT | FULL TEXT  

Diet and inflammation: a link to metabolic and cardiovascular diseases
Esposito and Giugliano
Eur Heart J 2006;27:15-20.
ABSTRACT | FULL TEXT  

Myocardial infarction and heart failure in the db/db diabetic mouse
Greer et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;290:H146-H153.
ABSTRACT | FULL TEXT  

Urinary Albumin Excretion and Its Relation With C-Reactive Protein and the Metabolic Syndrome in the Prediction of Type 2 Diabetes
Brantsma et al.
Diabetes Care 2005;28:2525-2530.
ABSTRACT | FULL TEXT  

Dietary pattern, inflammation, and incidence of type 2 diabetes in women
Schulze et al.
Am. J. Clin. Nutr. 2005;82:675-684.
ABSTRACT | FULL TEXT  

Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers
Hetzel et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1804-1809.
ABSTRACT | FULL TEXT  

Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction
Fung et al.
Am. J. Clin. Nutr. 2005;82:163-173.
ABSTRACT | FULL TEXT  

Subclinical Inflammation and Vascular Dysfunction in Women with Previous Gestational Diabetes Mellitus
Heitritter et al.
J. Clin. Endocrinol. Metab. 2005;90:3983-3988.
ABSTRACT | FULL TEXT  

Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial
Schaumberg et al.
Circulation 2005;111:2446-2453.
ABSTRACT | FULL TEXT  

A Burning Question: Does an Adipokine-Induced Activation of the Immune System Mediate the Effect of Overnutrition on Type 2 Diabetes?
Tataranni and Ortega
Diabetes 2005;54:917-927.
ABSTRACT | FULL TEXT  

Endothelial-Dependent Vasodilation and Incidence of Type 2 Diabetes in a Population of Healthy Postmenopausal Women
Rossi et al.
Diabetes Care 2005;28:702-707.
ABSTRACT | FULL TEXT  

Recombinant Methionyl Human Leptin Administration to Achieve High Physiologic or Pharmacologic Leptin Levels Does Not Alter Circulating Inflammatory Marker Levels in Humans with Leptin Sufficiency or Excess
Chan et al.
J. Clin. Endocrinol. Metab. 2005;90:1618-1624.
ABSTRACT | FULL TEXT  

Microplate ELISAs for Soluble VCAM-1 and ICAM-1
Chang et al.
Annals of Clinical & Laboratory Science 2005;35:312-317.
ABSTRACT | FULL TEXT  

Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?
Armitage et al.
J. Physiol. 2004;561:355-377.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.